Teveten (eprosartan mesylate)
Company: SmithKline BeechamApproval Status: Approved December 1997
Treatment for: hypertension
Areas: Cardiovascular / Cardiology; Diabetes / Endocrinology
Possible similar drugs: Teveten
| General Information | Mechanism of Action |
General Information
Teveten was approved for the treatment of hypertension, as either a monotherapy or for use in combination with other antihypertensives.
Mechanism of Action
Teveten is an angiotensin II antagonist.
Teveten Drug Information
The Teveten drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
